Monash receives largest share of federal medical research funding
7 December 2019 Monash University has been awarded more than $76 million in the latest round of National Health and Medical Research Council (NHMRC) funding to conduct vital research. Federal Health Minister, the Hon. Greg Hunt, today announced…
$437 million to improve the health of all Australians
7 December 2019 From the Health Minister, the Hon. Greg Hunt The Morrison Government is investing $437 million in ground-breaking health and medical research projects across Australia aimed at delivering better treatments, diagnosis and care. A total of 495…
Supercharging cellular immune therapies to combat solid tumours
9 December 2019 Cellular immune therapies are revolutionising cancer treatment and have been especially effective at combating blood cancers; now a team at Peter Mac and Monash Biomedicine Discovery Institute (BDI), led by Professor Tony Tiganis, may have…
Medicinal Cannabis Industry Grows Jobs In Gippsland
6 December 2019 From the Premier Victoria’s first dedicated commercial medicinal cannabis processing facility is open – giving more people access to life-changing treatment and creating local jobs. Premier Daniel Andrews today joined Member for Bass Jordan Crugnale…
Trajan accelerating adoption and growth of microsampling technologies
6 December 2019 Melbourne, Victoria, Australia Trajan Scientific and Medical (Trajan) announce the appointment of two new roles in their expanding Microsampling business to support global adoption of the portfolio. Led by Dr Anne Collins, the Microsampling business…
Trailblazing entrepreneurs on track to commercial success and healthcare impact
6 December 2019 Last night, the very best of our nation’s innovation ecosystem helped promising entrepreneurs strike out towards commercial success and healthcare impact at the MedTech’s Got Talent Challenge Gala Finals. At MedTech’s black-tie night of nights,…
Cymerus™ MSCs Effective in Preclinical Model of Sepsis
5 December 2019 Melbourne, Australia: Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX: CYP), announced today that it has received positive efficacy data from preclinical studies of its Cymerus™ mesenchymal stem cells (MSCs) in a…
CSL Continues to Advance R&D Capabilities
4 December 2019 Unique portfolio mix of plasma, cell and gene therapy, recombinant proteins and antibody assets highlighted at Research & Development Briefing. SYDNEY, Australia – CSL Limited (ASX:CSL; USOTC:CSLLY) is steadily advancing its Research & Development (R&D) pipeline…
ANDHealth Appoints Leading Global Healthcare Analyst & Strategist to Management Team
4 December 2019 ANDHealth today announced the appointment of leading healthcare communicator, analyst and strategist, Iain Scott, to the role of VP Stakeholder Engagement. A globally accomplished strategist, analyst and communicator, Iain has more than 20 years’ experience…
Digital Health Revolution
4 December 2019 Research Australia and the BioMelbourne Network are championing a Digital Health Revolution for Australia. Embracing digital technologies provides the opportunity to improve health outcomes, promote wellbeing and a sustainable health system, but it is going…
Positive DARRT-1 Data in Late-Stage Prostate Cancer
2 December 2019 Sydney: Noxopharm (ASX: NOX), an Australian drug development company, reports positive end-of-study data from its DARRT-1 Phase 1b trial. Commentary: Noxopharm Executive Chairman and CEO, Graham Kelly PhD “This is exciting data that validates our…
Opthea Raises A$50 million in Institutional Placement
2 December 2019 Melbourne, Australia – Opthea Limited (Opthea or the Company) (ASX: OPT), a clinical-stage biopharmaceutical company developing novel biologic therapies to treat back-of-the-eye diseases, today announced that the company has received commitments from sophisticated and institutional…
